This inventor holds 1 USPTO granted patent. Top assignee: Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: The Innovations of Benjamin Gerlach
Introduction
Benjamin Gerlach is an accomplished inventor based in Arco, Italy. He has made significant contributions to the field of molecular biology, particularly in the development of compounds that target viral infections. His work is crucial in the ongoing battle against hepatitis C.
Latest Patents
Gerlach holds a patent for "Peptides and their use as inhibitors of hepatitis C virus ns3 protease." This patent describes compounds of formula (I) and their pharmaceutically acceptable salts and esters. These compounds serve as inhibitors of the hepatitis C virus (HCV) NS3 protease, which is vital for the virus's replication.
Career Highlights
Benjamin Gerlach is affiliated with the Istituto di Ricerche di Biologia Molecolare P. Angeletti Spa, where he conducts his research. His work has garnered attention for its potential to improve treatment options for those affected by hepatitis C.
Collaborations
Gerlach collaborates with esteemed colleagues, including Stefania Colarusso and Cristina Gardelli. Their combined expertise enhances the research efforts at their institution.
Conclusion
Benjamin Gerlach's innovative work in developing antiviral compounds showcases his dedication to advancing medical science. His contributions are paving the way for new treatments in the fight against hepatitis C.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile